课题基金 / 基金详情

Clinical and Economic Evaluation of Breast MRI for High-Risk Screening

Clinical and Economic Evaluation of Breast MRI for High-Risk Screening
乳腺 MRI 高风险筛查的临床和经济评估
批准号:
8257983
负责人:
Janie M Lee
金额:
$14.34万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-06-01 至 2013-06-30

项目摘要

项目成果

Janie M Lee的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Project Summary: My career goal is to become an independent clinical investigator dedicated to optimizing the application of imaging in the early detection of breast cancer, with the ultimate aim of increasing the effectiveness of breast cancer screening. My experiences to date in clinical breast imaging, decision analytic methodologies, and health services research are uniquely suited to carry out the proposed research. The goal of the proposed research is to evaluate the clinical and economic consequences of MRI screening for breast cancer in women with increased genetic risk of breast cancer (>20% lifetime risk, including BRCA gene mutation carriers). The proposed research will: 1) develop and refine a complex computer simulation model, which will integrate currently available data and surrogate endpoints, 2) apply the model to predict long-term health and economic outcomes of screening with mammography and MRI, alone or in combination, and 3) evaluate patient preferences regarding trade-offs involved in adding MRI to current screening regimens. The research described in this proposal will carry out the following three specific aims: 1) Refine a Markov Monte Carlo disease model of breast cancer natural history and outcomes. 2) Compare the clinical effectiveness and cost-effectiveness of screening strategies utilizing mammography and MRI. 3) Determine patient preferences regarding false-positive test results to improve model estimates of clinical effectiveness and cost-effectiveness. Relevance: The proposed research will use computer simulation modeling to estimate the benefits and costs of using breast MRI for screening women at increased genetic risk of breast cancer. The results of the proposed research will provide data essential for developing standardized guidelines for optimizing the role of MRI in breast cancer screening.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Five-year risk of interval-invasive second breast cancer.
间隔浸润性第二乳腺癌的五年风险。
DOI: 10.1093/jnci/djv109
发表时间: 2015
期刊: Journal of the National Cancer Institute
影响因子: --
作者: [Lee,JanieM, Buist,DianaSM, Houssami,Nehmat, Dowling,EmilyC, Halpern,ElkanF, Gazelle,GScott, Lehman,ConstanceD, Henderson,LouiseM, Hubbard,RebeccaA]
通讯作者: Hubbard,RebeccaA
DOI: 10.1177/0272989x13487605
发表时间: 2013-08
期刊: Medical decision making : an international journal of the Society for Medical Decision Making
影响因子: --
作者: [Swan JS, Kong CY, Lee JM, Itauma O, Halpern EF, Lee PA, Vavinskiy S, Williams O, Zoltick ES, Donelan K]
通讯作者: Donelan K
DOI: 10.1016/j.acra.2009.05.011
发表时间: 2009-11
期刊: ACADEMIC RADIOLOGY
影响因子: 4.8
作者: [Lee, Janie M., Halpern, Elkan F., Rafferty, Elizabeth A., Gazelle, G. Scott]
通讯作者: Gazelle, G. Scott
Toward evidence-based decisions in diagnostic radiology: a research and rating process for multiple decision-makers.
诊断放射学中的循证决策:针对多个决策者的研究和评级过程。
DOI: 10.1016/j.acra.2012.04.009
发表时间: 2012
期刊: Academic radiology
影响因子: 4.8
作者: [Ollendorf,DanielA, Blackmore,CCraig, Lee,JanieM]
通讯作者: Lee,JanieM
7
    Risk-based Imaging Strategies to Improve Breast Cancer Surveillance Outcomes
    Project 3
    Risk-based Imaging Strategies to Improve Breast Cancer Surveillance Outcomes
    Project 3
    国内基金
    海外基金
    补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
    靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
    • 批准号:
      JCZRQN202500010
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
    • 依托单位:
    对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
    • 批准号:
      2025JJ70209
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      雷芬芳
    • 依托单位:
    AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
    • 批准号:
      --
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      万荣
    • 依托单位: